Skip to Content
Merck
  • Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis.

Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis.

Journal of medicinal chemistry (2006-01-06)
Ravindranadh V Somu, Helena Boshoff, Chunhua Qiao, Eric M Bennett, Clifton E Barry, Courtney C Aldrich
ABSTRACT

A rationally designed nucleoside inhibitor of Mycobacterium tuberculosis growth (MIC(99) = 0.19 microM) that disrupts siderophore biosynthesis was identified. The activity is due to inhibition of the adenylate-forming enzyme MbtA which is involved in biosynthesis of the mycobactins.

MATERIALS
Product Number
Brand
Product Description

Supelco
Isoniazid, analytical standard, ≥99% (TLC)